Terns Pharmaceuticals, Inc.Terns Pharmaceuticals, Inc.Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc.

No trades
See on Supercharts

Price target

19.210.000.00%
The 7 analysts offering 1 year price forecasts for TERN have a max estimate of — and a min estimate of —.

Analyst rating

Based on 8 analysts giving stock ratings to TERN in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


TERN EPS for the last quarter is −0.28 USD despite the estimation of −0.32 USD. In the next quarter EPS is expected to reach −0.30 USD. Track more of Terns Pharmaceuticals, Inc. financials and stay on top of what is up with the company.
In the next quarter Terns Pharmaceuticals, Inc. revenue is expected to reach 0.00 USD. Check out Terns Pharmaceuticals, Inc. revenue and earnings and make informed decisions.
According to analysts, TERN price target is 19.21 USD with a max estimate of 34.00 USD and a min estimate of 7.50 USD. Check if this forecast comes true in a year, meanwhile watch Terns Pharmaceuticals, Inc. stock price chart and keep track of the current situation with TERN news and stock market news.
We've gathered opinions of 8 analysts rating TERN stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.